Nuovi dati

(1)

NUOVI DATI

Lucia Mentuccia

UOC Oncologia ASL Frosinone

SESSIONE: BREAST

(2)

Early Breast Cancer

• Integrating PI3K and CDK 4-6 inhibitors in the neoadjuvant treatment of ER + EBC LORELEI STUDY & NEOPAL STUDY

• Dual endocrine blockade as adjuvant therapy in ER+ EBC GEICAM 2006-10 TRIAL

• Escalating adjuvant therapy in HER2+ EBC EXTENET TRIAL

(3)

Early Breast Cancer

(4)

(5)

(6)

(7)

(8)

(9)

(10)

(11)

(12)

(13)

(14)

(15)

(16)

(17)

(18)

(19)

(20)

(21)

Early Breast Cancer

(22)

(23)

(24)

(25)

Median FU =6.3 yrs

(26)

Median FU =6.3 yrs

(27)

(28)

Early Breast Cancer

(29)

(30)

(31)

(32)

(33)

(34)

(35)

(36)

Metastatic Breast Cancer

• Predicting immunogenenicity in breast cancer KEYNOTE - 086 STUDY

• Consistent benefit across studies –class effect of CDK4/6 inhibitors MONARCH 3 TRIAL

(37)

Metastatic Breast Cancer

• Predicting immunogenenicity in breast cancer KEYNOTE - 086 STUDY

(38)

(39)

(40)

(41)

(42)

(43)

(44)

Metastatic Breast Cancer

• Predicting immunogenenicity in breast cancer KEYNOTE - 086 STUDY

(45)

(46)

(47)

(48)

(49)

(50)

(51)

(52)

(53)

(54)

(55)

(56)